Bristi Basu, MD

Articles by Bristi Basu, MD

Dr. Basu on Second-Line Therapy in HCC

September 28th 2018

Bristi Basu, MD, honorary consultant medical oncologist, University of Cambridge, discussed second-line therapy for patients with hepatocellular carcinoma.

Latest Updated Articles

Dr. Basu on Second-Line Therapy in HCC
Published: September 28th 2018 | Updated:

Bristi Basu, MD

Articles by Bristi Basu, MD

Dr. Basu on Second-Line Therapy in HCC

Latest Updated Articles

Trending on OncLive

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies

FDA Approves Larger Vial Size for Nelarabine Injection in T-ALL and T-LBL

Oncology Fellows Highlights 2025 ESMO Fellowship Winners